IL1B and chronic obstructive pulmonary disease: Indeed, Di Stefano et al,, suggested that the multimeric complex may be critical in COPD exacerbation [68], but not in stable COPD, as suggested by the inefficiency of Canakinumab, IL-1β blocking antibody, in stable patients [22] (Table I).